3 vials Save $98.75

CJC-1295 + Ipamorelin 10mg

Lyophilized research peptide

$168.74

Tesamorelin 10mg

Lyophilized research peptide

$199.99

SS-31 10mg

Lyophilized research peptide

$124.99

Research bundle · 3 vials

CJC-1295 + Ipamorelin 10mg, Tesamorelin 10mg + SS-31 10mg Research Bundle

USA Made, ≥99% Purity Per Compound

Separate retail vials: CJC-1295 + Ipamorelin 10mg (CJC-1295 No DAC 5mg + Ipamorelin 5mg); Tesamorelin 10mg; SS-31 10mg
USA manufactured in a Certified GMP California and Arizona laboratory.
≥99% purity target per compound with independent third-party HPLC, mass spectrometry, and batch-specific COAs

Combined retail value$493.72

Bundle saving−$98.75

$394.97 $493.72 Save $98.75

Each vial ships in its original retail format with its own batch COA

Dispatched from a US warehouse within 48 hours, tracked

Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

Disclaimer

For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.

Per-compound specifications

3 vials

Nothing in this bundle is co-formulated. Each vial keeps its own identity, purity target, and certificate, and is specified separately below.

Vial 01

CJC-1295 + Ipamorelin 10mg

Sequences

CJC-1295 No DAC: Y-(D-Ala)-DAIFTQSYRKVLAQLSARKLLQDILSR-NH2; Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH2

CAS: CJC-1295 No DAC: 446036-97-1; Ipamorelin: 170851-70-4
Molecular mass: CJC-1295 No DAC: 3,367.95 g/mol; Ipamorelin: 711.9 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Vial 02

Tesamorelin 10mg

Sequence

N-terminal trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL

CAS: 218949-48-5
Molecular mass: 5,136 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Vial 03

SS-31 10mg

Sequence

D-Arg-2,6-dimethyl-Tyr-Lys-Phe-NH2

CAS: 736992-21-5
Molecular mass: 639.8 g/mol
Purity target: ≥99%
Form: Lyophilized Powder

Form: 3 Separate Lyophilized Powders
Purity target: ≥99% per compound (3rd-Party HPLC Tested)
Origin: All Included Products: Synthesized, Formulated & Packaged in CA/AZ, USA
Storage: Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

What is the CJC-1295 + Ipamorelin 10mg, Tesamorelin 10mg + SS-31 10mg Research Bundle?

This three-vial research bundle combines CJC-1295 + Ipamorelin 10mg, Tesamorelin 10mg, and SS-31 10mg. The CJC-1295 + Ipamorelin vial combines 5mg of each peptide and represents both GHRH-receptor and ghrelin-receptor signaling. Tesamorelin is a modified 44-amino-acid GHRH analog used to study receptor activation and downstream growth-hormone-axis signals. SS-31 is a synthetic tetrapeptide studied for its interaction with cardiolipin in the inner mitochondrial membrane.

Together, the set supports controlled work across GHRH-receptor, ghrelin-receptor, growth-hormone-axis, cardiolipin, and mitochondrial-membrane signaling. Each retail product stays in its own lyophilized vial, so the bundle does not create a new formulation or establish a proven combined effect.

How It Works

CJC-1295 + Ipamorelin uses two upstream signals: CJC-1295 No DAC engages the GHRH receptor, while Ipamorelin engages GHS-R1a.

Tesamorelin models GHRH-receptor signaling: Receptor engagement supports controlled measurement of cAMP-linked pituitary and downstream pathway markers.

SS-31 focuses on mitochondrial membrane organization: Its cardiolipin interaction supports research into electron-transport structure and mitochondrial response signaling.

Analytical data

One certificate per vial

Independent third-party HPLC assesses each compound against its ≥99% purity target, while mass spectrometry confirms identity. For each vial, the results are documented in one combined, batch-specific COA report.

Lot: CJI433
Reported: 2026-06-01
Identity (LC-MS): Confirmed
Purity (HPLC-UV): 99.95%
Net content: Ipamorelin - 5.60 mg, CJC-1295 - 5.48 mg
Appearance: White lyophilized powder

Download COA

Lot: T522
Reported: 2026-04-23
Identity (LC-MS): Confirmed
Purity (HPLC-UV): 99.58%
Net content: 9.85 mg
Appearance: White lyophilized powder

Download COA

Lot: 55432
Reported: 2026-06-01
Identity (LC-MS): Confirmed
Purity (HPLC-UV): 99.77%
Net content: 11.83 mg
Appearance: White lyophilized powder

Download COA

Why Source from 321 Peptides?

Domestic accountability.

All included compounds are synthesized, manufactured, formulated, finished, and packaged in Certified GMP laboratory facilities in California and Arizona—never sourced from overseas or Mexico. That creates direct domestic supply-chain accountability from production through fulfillment.

Verification you can inspect.

Independent third-party HPLC evaluates each compound against its ≥99% purity target, while mass spectrometry confirms molecular identity. For each vial, the results are documented in one combined, batch-specific Certificate of Analysis report.

Protected in transit.

Every included product is freeze-dried to help preserve stability during storage and shipping. Rapid domestic fulfillment reduces unnecessary time and handling.

Lot history 12 released lots

Every batch released under each vial in this bundle, with the figure reported for each. Vials are shipped from current stock.

Compound	Lot	Reported	Purity	Net content	COA
CJC-1295 + Ipamorelin 10mg	CJI433	2026-06-01	99.95%	Ipamorelin - 5.60 mg, CJC-1295 - 5.48 mg	PDF
	CJ-48928	2026-05-12	99.64%	10.04 mg	Pending
	CJ-49505	2026-04-30	99.88%	10.05 mg	Pending
	CJ-50082	2026-02-25	99.71%	10.06 mg	Pending
Tesamorelin 10mg	TE-32025	2026-04-23	99.46%	10.00 mg	Pending
	T522	2026-04-23	99.58%	9.85 mg	PDF
	TE-33179	2026-04-08	99.83%	10.02 mg	Pending
	TE-32602	2026-03-19	99.58%	10.01 mg	Pending
SS-31 10mg	55432	2026-06-01	99.77%	11.83 mg	PDF
	SS-45099	2026-04-30	99.58%	10.06 mg	Pending
	SS-46253	2026-04-23	99.49%	10.08 mg	Pending
	SS-45676	2026-02-25	99.83%	10.07 mg	Pending

Frequently Asked Questions

What comes in the CJC-1295 + Ipamorelin 10mg, Tesamorelin 10mg + SS-31 10mg bundle?

The bundle includes one CJC-1295 + Ipamorelin 10mg (CJC-1295 No DAC 5mg + Ipamorelin 5mg) vial, one Tesamorelin 10mg vial, and one SS-31 10mg vial. Each product arrives separately in lyophilized form with batch-specific COA documentation.

What research pathways are represented in this bundle?

The bundle spans GHRH-receptor, ghrelin-receptor, growth-hormone-axis, cardiolipin, and mitochondrial-membrane signaling. Each compound retains a distinct experimental profile, and the bundle does not establish clinical synergy.

Are these FDA-approved prescription products?

No. Some included active ingredients also appear in FDA-approved finished medicines, but the research vials in this bundle are not those approved products or substitutes. Every vial is supplied exclusively for controlled, non-clinical research.